[Form 4] My Size, Inc. Insider Trading Activity

Rhea-AI Filing Summary

My Size, Inc. (MYSZ) reported insider share purchases by its CEO and director Ronen Luzon. On 11/20/2025 he bought 10,500 shares of common stock at $0.76 per share and another 3,000 shares at $0.77 per share in open-market transactions.

Following these purchases, he directly owns 57,500 shares of My Size common stock. The filing reports no derivative security transactions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Luzon Ronen

(Last) (First) (Middle)

C/O MY SIZE INC.

HANEGEV 4, POB 1026

(Street)

AIRPORT CITY L3 7019900

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
My Size, Inc. [ MYSZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/20/2025		P		10,500	A	$0.76	54,500	D
Common Stock	11/20/2025		P		3,000	A	$0.77	57,500	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Ronen Luzon	11/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did My Size (MYSZ) disclose?

My Size disclosed that its CEO and director Ronen Luzon purchased shares of the company’s common stock in open-market transactions reported on a Form 4.

How many My Size (MYSZ) shares did the CEO buy and at what prices?

On 11/20/2025, Ronen Luzon bought 10,500 My Size shares at $0.76 per share and 3,000 shares at $0.77 per share.

How many My Size (MYSZ) shares does the CEO own after the transactions?

After the reported purchases, Ronen Luzon directly owns 57,500 shares of My Size common stock.

What is Ronen Luzon’s role and relationship to My Size (MYSZ)?

Ronen Luzon is reported as both a director and an officer of My Size, serving as the company’s Chief Executive Officer.

Were any derivative securities reported in this My Size (MYSZ) Form 4?

The Form 4 includes a table for derivatives but shows no derivative securities acquired, disposed of, or beneficially owned in the reported transactions.

Is the My Size (MYSZ) Form 4 filed by one or multiple reporting persons?

The filing is indicated as a Form filed by One Reporting Person, identifying only Ronen Luzon as the reporting person.